EUVIMEDEUVIMED entdecken
Open Access

Physician‐reported barriers and facilitators to thyroid hormone deprescribing in older adults

Brandon Moretti, Rachel Livecchi, Stephanie R Taylor, Susan C Pitt, Brittany L Gay, Megan R Haymart, Arti Bhan, Jennifer Perkins, Maria Papaleontiou

Journal of the American Geriatrics Society · 2025-02 · 73 (2) · 566-573

DOI: 10.1111/jgs.19219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 11.10.2024. Verfasst von Brandon Moretti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Deprescriptions, Thyroid Hormones, Practice Patterns, Physicians'. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, University of Michigan, U.S. Deprescribing Research Network Pilot Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thyroid hormone is one of the most commonly prescribed medications in the United States. Misuse of and overtreatment with thyroid hormone is common in older adults and can lead to cardiovascular and skeletal adverse events. Even though deprescribing can reduce inappropriate care, no studies have yet explored specific barriers and facilitators to guide thyroid hormone deprescribing in older adults (defined as discontinuation of thyroid hormone when initiated without an appropriate indication or dose reduction in those overtreated).

Methods

We conducted semi‐structured interviews with 19 endocrinologists, geriatricians, and primary care physicians who prescribe thyroid hormone. Interviews were completed between July 2020 and December 2021 via two‐way video conferencing. We used both an inductive and deductive content analysis guided by the Theoretical Domains Framework to evaluate transcribed and coded participant responses. Thematic analysis characterized themes related to barriers and facilitators to thyroid hormone deprescribing practices in older adults.

Results

The most commonly reported barriers to thyroid hormone deprescribing were related to patient‐level factors, followed by physician‐ and system‐level factors. Patient factors included patients' perceived need for thyroid hormone use and patient anxiety/concerns about potential side effects related to thyroid hormone dose reduction, patient lack of knowledge, and misinformation regarding deprescribing. Physician‐ and system‐level barriers included clinic visit time constraints, physician inertia, physician lack of knowledge about deprescribing, perceived lack of sufficient patient follow‐up, and electronic health record limitations. The most prominent physician‐reported facilitators to thyroid hormone deprescribing were effective physician‐to‐patient communication, and positive physician–patient relationship, including patients' trust in their treating physician.

Conclusion

Barriers and facilitators to thyroid hormone deprescribing in older adults were reported at multiple levels including patient‐, physician‐, and system‐level factors. Interventions to improve thyroid hormone deprescribing in older adults should aim to improve patient education and expectations, increase multidisciplinary physician awareness, and overcome physician inertia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeprescriptionsThyroid HormonesPractice Patterns, Physicians'HumansFemaleMaleAgedMiddle AgedInterviews as TopicUnited StatesQualitative Research

Stichwörter der Autor:innen

deprescribinglow‐value careolder adultsthyroid hormone

Substanzen

Thyroid Hormones

Autor:innen und Institutionen

  • Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Internal Medicine, Mercy Health - St. Vincent Medical Center, Toledo, Ohio, USA.
  • Division of Endocrine Surgery, Department of General Surgery, University of Michigan, Ann Arbor, Michigan, USA.
  • Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Department of Internal Medicine, Henry Ford Health System, Detroit, Michigan, USA.
  • Division of Endocrinology and Metabolism, Department of Medicine and Surgery, University of California San Francisco, San Francisco, California, USA.
  • Institute of Gerontology, University of Michigan, Ann Arbor, Michigan, USA.

Förderung

  • NIA NIH HHS
  • University of Michigan
  • U.S. Deprescribing Research Network Pilot Award
  • National Institute on Aging

Zitieren

APA

Moretti, B., Livecchi, R., Taylor, S. R., Pitt, S. C., Gay, B. L., Haymart, M. R., Bhan, A., Perkins, J., & Papaleontiou, M. (2025). Physician‐reported barriers and facilitators to thyroid hormone deprescribing in older adults. Journal of the American Geriatrics Society, 73(2), 566-573. https://doi.org/10.1111/jgs.19219

Vancouver

Moretti B, Livecchi R, Taylor SR, Pitt SC, Gay BL, Haymart MR, et al. Physician‐reported barriers and facilitators to thyroid hormone deprescribing in older adults. Journal of the American Geriatrics Society. 2025;73(2):566-573. doi:10.1111/jgs.19219

BibTeX
@article{Moretti2025,
  author = {Moretti, Brandon and Livecchi, Rachel and Taylor, Stephanie R and Pitt, Susan C and Gay, Brittany L and Haymart, Megan R and Bhan, Arti and Perkins, Jennifer and Papaleontiou, Maria},
  title = {Physician‐reported barriers and facilitators to thyroid hormone deprescribing in older adults},
  journal = {Journal of the American Geriatrics Society},
  year = {2025},
  volume = {73},
  number = {2},
  pages = {566--573},
  doi = {10.1111/jgs.19219}
}
Kostenlos starten →